Home > Financial Ratios > DR LAL PATHLABS

DR LAL PATHLABS
Core EBITDA Growth

    Back to All Ratios
DR LAL PATHLABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for DR LAL PATHLABS
Please provide your vote to see the results

DR LAL PATHLABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 16.3127.63-13.3225.7722.32

What is the latest Core EBITDA Growth ratio of DR LAL PATHLABS ?

The latest Core EBITDA Growth ratio of DR LAL PATHLABS is 16.31 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202516.31
Mar202427.63
Mar2023-13.32
Mar202225.77
Mar202122.32

How is Core EBITDA Growth of DR LAL PATHLABS Trending?

Years Core EBITDA Growth % Change
Mar2025 16.31
-40.97
Mar2024 27.63
Positive
Mar2023 -13.32
Negative
Mar2022 25.77
15.46
Mar2021 22.32 -

Other Financial Ratios of DR LAL PATHLABS


Compare Core EBITDA Growth ratio of peers of DR LAL PATHLABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR LAL PATHLABS ₹25,176.0 Cr 0.6% 7.2% -1% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹118,495.0 Cr -3.7% 2.2% 32.5% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹104,184.0 Cr -1.4% 3.5% 13.6% Stock Analytics
FORTIS HEALTHCARE ₹61,102.5 Cr 1.7% 7.3% 66.9% Stock Analytics
NARAYANA HRUDAYALAYA ₹40,588.1 Cr 1.8% 0% 54.4% Stock Analytics
GLOBAL HEALTH ₹34,682.1 Cr -3.6% 11.4% 8.1% Stock Analytics


DR LAL PATHLABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR LAL PATHLABS

0.6%

7.2%

-1%

SENSEX

-0.5%

-0.3%

1%


You may also like the below Video Courses